To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Time BioVentures raises $100m for debut biotech fund
The early-stage life sciences venture firm's limited partners include Chris Sacca, Ron Burkle and Wildcat Partner Holdings.
